Activation of T Lymphocytes with Anti-PDL1-BiTE in the Presence of Adipose-Derived Mesenchymal Stem Cells (ASCs).
Leila MoeinzadehAmin RamezaniFereshteh MehdipourMahsa Yazdanpanah-SamaniMahboobeh RazmkhahPublished in: BioMed research international (2023)
Overall, anti-PDL1-BiTE selectively depletes PDL1pos cells and represents a new immunotherapeutic approach. It would increase the accumulation of T cells and can improve the prognosis of PDL1pos cancers in spite of the immunomodulatory effects of ASCs and C.M.